Geneseeq Technology Inc.

Geneseeq Technology Inc. is a research-driven company providing cutting-edge next-generation sequencing (NGS) technology to accelerate precision cancer care.  Its portfolio spans comprehensive genomic profiling across tumor types, cancer-specific diagnostic panels, minimal residual disease (MRD) monitoring, and multi-cancer early detection (MCED) solutions.

The company’s flagship GeneseeqPrime® tumor profiling assay is now FDA-cleared, CE-IVD marked, and NMPA-approved, ensuring accessibility across major jurisdictions.